Capitalizing on a Teachable Moment to Promote Smoking Cessation
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02276664 |
Recruitment Status :
Completed
First Posted : October 28, 2014
Last Update Posted : August 13, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Smoking Cessation | Behavioral: Self-Help (SHI) Behavioral: Usual Care (UC) | Not Applicable |
Conduct Formative Research (Months 1 - 4): Identification of emergent themes and responses to existing booklets.
Adapt and Refine Booklets (Months 5 - 8): Advanced drafts of booklets.
Final Reactions to Draft Booklets (Months 9 - 12): Series of smoking cessation booklets for spiral computed tomography (CT) patients.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 35 participants |
Allocation: | Randomized |
Intervention Model: | Factorial Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Capitalizing on a Teachable Moment to Promote Smoking Cessation |
Actual Study Start Date : | October 20, 2014 |
Actual Primary Completion Date : | June 21, 2019 |
Actual Study Completion Date : | June 21, 2019 |

Arm | Intervention/treatment |
---|---|
No Intervention: Study 1 - Focus Groups
Using focus group methodology, investigators will identify and explore new content topics for inclusion in smoking cessation booklets and gather feedback about the existing Stop Smoking for Good booklets regarding tone and message design. Results will be used to modify and adapt the existing cessation intervention.
|
|
Experimental: Study 2 - Self-Help Intervention (SHI)
The SHI arm will receive the intervention developed in Study I.
|
Behavioral: Self-Help (SHI)
The newly revised Stop Smoking for Good booklets. |
Active Comparator: Study 2 - Usual Care (UC)
The UC arm will receive the existing Clearing the Air smoking-cessation manual.
|
Behavioral: Usual Care (UC)
The existing Clearing the Air smoking-cessation manual published by the National Cancer Institute (NCI). |
- Study 1 - Completion of Formative Evaluation [ Time Frame: Up to 12 months ]Complete formative research to adapt and refine the existing Stop Smoking for Good booklets.
- Study 2 - Rate of Seven-Day Abstinence [ Time Frame: Seven-day abstinence will be assessed at each follow-up, allowing for calculation of point-prevalence abstinence rates. For this pilot, we will not bioverify self-reported abstinence. ]Up to 9 months
- Rate of Intervention Demand [ Time Frame: Up to 9 months ]Demand will be estimated by noting accrual rates into the study.
- Degree of Practicality [ Time Frame: Up to 9 months ]Practicality encompasses the degree to which investigators are able to carry out all the piloted elements of the planned randomized control trial (RCT) successfully and efficiently (i.e., recruitment, screening, randomization, and follow-up).

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Study 1
- Participants for Study I will be drawn from a list of patients who have received a CT scan at the Moffitt Cancer Center
- Smoked at least one cigarette per week prior to undergoing the CT scan
- Able to speak and read English
Study 2
- Smoked at least one cigarette over the past week
- Able to read English

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02276664
United States, Florida | |
H Lee Moffitt Cancer Center | |
Tampa, Florida, United States, 33612 |
Principal Investigator: | Thomas Brandon, Ph.D. | H. Lee Moffitt Cancer Center and Research Institute |
Responsible Party: | H. Lee Moffitt Cancer Center and Research Institute |
ClinicalTrials.gov Identifier: | NCT02276664 |
Other Study ID Numbers: |
MCC-17952 4KB05 ( Other Identifier: James and Esther King Biomedical Research Program ) |
First Posted: | October 28, 2014 Key Record Dates |
Last Update Posted: | August 13, 2020 |
Last Verified: | August 2020 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
lung cancer prevention |